Literature DB >> 17016234

Prevalence of risk factors for hepatitis C virus in HIV-infected and HIV/hepatitis C virus-coinfected patients.

Srigayatri Bollepalli1, Kathleen Mathieson, Curt Bay, Amy Hillier, John Post, David H Van Thiel, Abdul Nadir.   

Abstract

METHODS: A sample of patients with HIV completed a questionnaire identifying their demographic characteristics and risk factors for hepatitis C virus (HCV). A chart review was conducted to confirm the information obtained using the questionnaire. Risk factors associated with coinfection status at alpha level of 0.1 in univariate analysis were entered into a multivariate Cox regression model.
RESULTS: Of the 242 HIV-positive patients analyzed, 168 were HIV-infected and 74 were HIV/HCV-coinfected. Risk factors that were significantly different between HIV-monoinfected and HIV/HCV-coinfected subjects included intravenous drug use, snorting drugs, sharing razors or toothbrushes, being in prison, the presence of one or more tattoos, sex for money or drugs, sex with an intravenous drug user and man who has sex with men. In a multivariate regression model, only intravenous drug use remained as a significant risk factor/predictor of HCV/HIV coinfection. A subanalysis identified risk factors more prevalent among coinfected men who have sex with men, including intravenous drug use, sharing razors/toothbrushes, tattoos, sex for money or drugs, sex with an intravenous drug user, and a history of having 11 or more sexual partners. A history of having had a sexually transmitted disease and 11 or more sex partners was more prevalent among HIV-monoinfected men who have sex with men.
CONCLUSIONS: HIV/HCV coinfection was associated with intravenous drug use but not with sexual risk factors.

Entities:  

Mesh:

Year:  2007        PMID: 17016234     DOI: 10.1097/01.olq.0000240295.35457.b1

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  17 in total

Review 1.  Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes.

Authors:  Yaron Rotman; T Jake Liang
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

2.  Hepatocellular carcinoma in patients co-infected with hepatitis C virus and human immunodeficiency virus.

Authors:  Dimitrios Dimitroulis; Serena Valsami; Eleftherios Spartalis; Emmanuel Pikoulis; Gregory Kouraklis
Journal:  World J Hepatol       Date:  2013-06-27

Review 3.  Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis.

Authors:  L M Kucirka; H Sarathy; P Govindan; J H Wolf; T A Ellison; L J Hart; R A Montgomery; R L Ros; D L Segev
Journal:  Am J Transplant       Date:  2011-03-14       Impact factor: 8.086

4.  Optimizing hepatitis C therapy in HIV/hepatitis C virus (HCV) coinfected patients: Analysis of HCV viral kinetics on treatment.

Authors:  Paul Damien James; David Kh Wong
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

5.  Co-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlates.

Authors:  Fernando H Wolff; Sandra C Fuchs; Nêmora N T Barcellos; Paulo Ricardo de Alencastro; Maria Letícia R Ikeda; Ajácio B M Brandão; Maicon Falavigna; Flávio D Fuchs
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

Review 6.  Management of hepatitis C virus infection in HIV/HCV co-infected patients: clinical review.

Authors:  Ashwani-K Singal; Bhupinderjit S Anand
Journal:  World J Gastroenterol       Date:  2009-08-14       Impact factor: 5.742

Review 7.  Role of liver transplantation in human immunodeficiency virus positive patients.

Authors:  Deepak Joshi; Kosh Agarwal
Journal:  World J Gastroenterol       Date:  2015-11-21       Impact factor: 5.742

8.  Hepatitis C and human immunodeficiency virus risk behaviors in polydrug users on methadone maintenance.

Authors:  Jessica Willner-Reid; Katherine A Belendiuk; David H Epstein; John Schmittner; Kenzie L Preston
Journal:  J Subst Abuse Treat       Date:  2007-10-10

9.  High rate of seronegative HCV infection in HIV-positive patients.

Authors:  Takako Utsumi; Lindawati Alimsardjono; Mochamad Amin; Myrna Adianti; Yoshihiko Yano; Yoshitake Hayashi; Hak Hotta; Maria Inge Lusida
Journal:  Biomed Rep       Date:  2013-10-29

10.  Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received.

Authors:  Davide Motta; Nigritella Brianese; Emanuele Focà; Paola Nasta; Franco Maggiolo; Massimiliano Fabbiani; Giuliana Cologni; Simona Di Giambenedetto; Massimo Di Pietro; Nicoletta Ladisa; Laura Sighinolfi; Silvia Costarelli; Filippo Castelnuovo; Carlo Torti
Journal:  AIDS Res Ther       Date:  2012-06-15       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.